Gilead Sciences, Inc. (GILD)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 84.17 |
| Open | 84.30 |
| Bid | 84.43 x 1000 |
| Ask | 84.72 x 1000 |
| Day's range | 83.98 - 84.95 |
| 52-week range | 62.07 - 87.87 |
| Volume | |
| Avg. volume | 6,548,460 |
| Market cap | 105.314B |
| Beta (5Y monthly) | 0.20 |
| PE ratio (TTM) | 103.16 |
| EPS (TTM) | 0.82 |
| Earnings date | 07 Nov 2024 |
| Forward dividend & yield | 3.08 (3.64%) |
| Ex-dividend date | 13 Sept 2024 |
| 1y target est | 82.49 |
Simply Wall St.Gilead Sciences' (NASDAQ:GILD) investors will be pleased with their favorable 62% return over the last five years
When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Furthermore...
ZacksPraxis Precision Medicines (PRAX) Moves 8.4% Higher: Will This Strength Last?
Praxis Precision Medicines (PRAX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
ZacksGILD Grants Right for HIV PrEP Candidate to Six Generic Companies
Gilead signs non-exclusive, royalty-free voluntary licensing agreements with six generic companies to market its investigational medicine, lenacapavir, for HIV Prevention.
© 2024 Yahoo. All rights reserved.